Evidence map›Paper›PMID 33712625›Full record

ArticleNPJ systems biology and applications2021

Computational analysis of fused co-expression networks for the identification of candidate cancer gene biomarkers.

Sara Pidò, Gaia Ceddia, Marco Masseroli

Abstract read
In one paragraph

Article in NPJ systems biology and applications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Heliyon · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sara PidòDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy. sara.pido@polimi.it.ORCID 0000-0003-1425-1719
Gaia CeddiaDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy. gaia.ceddia@polimi.it.ORCID 0000-0001-9512-7781
Marco MasseroliDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.ORCID 0000-0003-2574-1174

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The complexity of cancer has always been a huge issue in understanding the source of this disease. However, by appreciating its complexity, we can shed some light on crucial gene associations across and in specific cancer types. In this study, we develop a general framework to infer relevant gene biomarkers and their gene-to-gene associations using multiple gene co-expression networks for each cancer type. Specifically, we infer computationally and biologically interesting communities of genes from kidney renal clear cell carcinoma, liver hepatocellular carcinoma, and prostate adenocarcinoma data sets of The Cancer Genome Atlas (TCGA) database. The gene communities are extracted through a data-driven pipeline and then evaluated through both functional analyses and literature findings. Furthermore, we provide a computational validation of their relevance for each cancer type by comparing the performance of normal/cancer classification for our identified gene sets and other gene signatures, including the typically-used differentially expressed genes. The hallmark of this study is its approach based on gene co-expression networks from different similarity measures: using a combination of multiple gene networks and then fusing normal and cancer networks for each cancer type, we can have better insights on the overall structure of the cancer-type-specific network.

Indexed as

Biomarkers, TumorLiver NeoplasmsComputational BiologyGene Expression ProfilingGenes, NeoplasmHumansMaleBiomarkers, Tumor

Identifiers

PMID33712625
PMCPMC7955132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.